4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-025826
Chief Business Officer sold 45,000 shares at $26.00 ($1,170,000)
- Chief Business Officer acquired 32,677 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2022-07-06 | Option exercise | +32,677 | $2.08 | $67,968 | 69,123 | D |
| Robb Gary Charles Chief Business Officer | 2022-07-06 | Sale | −45,000 | $26.00 | $1,170,000 | 24,123 | D |
| Derivatives | |||||||
| Robb Gary Charles Chief Business Officer | 2022-07-06 | Option exercise · Stock option (right to buy) | +32,677 | 114,964 | D | ||
| Open-market sales · 45,000 sh · avg $26.00 · $1,170,000 | |||||||
Loading xslF345X03/doc4.xml…